Zoha Momin

ORCID: 0000-0002-2247-7665
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • Bacillus and Francisella bacterial research
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • Cutaneous lymphoproliferative disorders research
  • Urticaria and Related Conditions
  • HIV/AIDS drug development and treatment
  • Dermatological and Skeletal Disorders
  • Autoimmune Bullous Skin Diseases
  • Ear and Head Tumors
  • melanin and skin pigmentation
  • vaccines and immunoinformatics approaches
  • Mast cells and histamine
  • Ear Surgery and Otitis Media
  • Reconstructive Facial Surgery Techniques
  • SARS-CoV-2 detection and testing
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Biochemical and Molecular Research
  • Cytomegalovirus and herpesvirus research
  • Head and Neck Surgical Oncology
  • Histiocytic Disorders and Treatments
  • HIV-related health complications and treatments
  • T-cell and B-cell Immunology
  • COVID-19 Clinical Research Studies
  • Vascular Tumors and Angiosarcomas

The University of Texas Southwestern Medical Center
2022-2024

Southwestern Medical Center
2023

Baylor College of Medicine
2020-2022

American Academy of Dermatology
2022

HIV-1 is a chronic disease managed by strictly adhering to daily antiretroviral therapy (ART). However, not all people living with have access ART, and those may adhere treatment regimens increasing viral load progression. Here, subcutaneous nanofluidic implant was used as long-acting (LA) drug delivery platform address these issues. The device loaded tenofovir alafenamide (TAF) implanted in treatment-naïve simian HIV (SHIV)-positive nonhuman primates (NHP) for month. We monitored...

10.3390/pharmaceutics12100981 article EN cc-by Pharmaceutics 2020-10-17

There is an urgent need for accessible and low-cost COVID-19 vaccine suitable low- middle-income countries. Here, we report on the development of a SARS-CoV-2 receptor-binding domain (RBD) protein, expressed at high levels in yeast (Pichia pastoris), as candidate against COVID-19. After introducing two modifications into wild-type RBD gene to reduce yeast-derived hyperglycosylation improve stability during protein expression, show that recombinant RBD219-N1C1, equivalent (RBD219-WT) vitro...

10.1080/21645515.2021.1901545 article EN other-oa Human Vaccines & Immunotherapeutics 2021-04-13

Pre-exposure prophylaxis (PrEP) using antiretroviral oral drugs is effective at preventing HIV transmission when individuals adhere to the dosing regimen. Tenofovir alafenamide (TAF) a potent drug, with numerous long-acting (LA) delivery systems under development improve PrEP adherence. However, none has undergone preventive efficacy assessment. Here we show that LA TAF novel subcutaneous nanofluidic implant (nTAF) confers partial protection from transmission. We demonstrate sustained...

10.1002/adtp.202000163 article EN cc-by-nc-nd Advanced Therapeutics 2020-12-16

Abstract There is an urgent need for accessible and low-cost COVID-19 vaccine suitable low- middle-income countries. Here we report on the development of a SARS-CoV-2 receptor-binding domain (RBD) protein, expressed at high levels in yeast ( Pichia pastoris ), as candidate against COVID-19. After introducing two modifications into wild-type RBD gene to reduce yeast-derived hyperglycosylation improve stability during protein expression, show that recombinant RBD219-N1C1, equivalent...

10.1101/2020.11.04.367359 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-11-05

Abstract Pre-exposure prophylaxis (PrEP) using antiretroviral oral drugs is effective at preventing HIV transmission when individuals adhere to the dosing regimen. Tenofovir alafenamide (TAF) a potent drug, with numerous long-acting (LA) delivery systems under development improve PrEP adherence. However, none has undergone preventive efficacy assessment. Here we show that LA TAF novel subcutaneous nanofluidic implant (nTAF) confers partial protection from transmission. We demonstrate...

10.1101/2020.05.13.091694 preprint EN cc-by-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-05-17

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 Wuhan, China, and then rapidly spread causing an unprecedented pandemic. A robust serological assay is needed to evaluate vaccine candidates better understand the epidemiology of disease (COVID-19).We used full-length spike (S) protein SARS-CoV-2 for development qualitative quantitative IgG IgA anti-S enzyme linked immunosorbent assays (ELISA). total 320 sera were comprised pandemic from infected...

10.3389/fimmu.2021.693462 article EN cc-by Frontiers in Immunology 2021-10-08

Chronic spontaneous urticaria presents with wheals and/or angioedema for >6 weeks without any specific triggers. The incidence of chronic is increased in patients comorbid autoimmune conditions. Here, we present a case 9-year-old type 1 diabetes and thyroid disease who first presented insulin pump site reactions concerning an insulin-related allergy. patient was successfully treated antihistamines later immunosuppression resumption therapy remission symptoms 18 months after onset.

10.1177/2050313x241248383 article EN cc-by-nc SAGE Open Medical Case Reports 2024-01-01

Abstract Introduction Compared with previous geographically localized outbreaks of monkeypox (MPOX), the scale 2022 global mpox outbreak has been unprecedented, yet clinical features this remain incompletely characterized. Methods We identified patients diagnosed by polymerase chain reaction (PCR; n = 36) from July to September at a single, tertiary care institution in USA. Demographics, presentation, infection course, and histopathologic were reviewed. Results Conclusion Men who have sex...

10.1111/hiv.13517 article EN cc-by-nc HIV Medicine 2023-06-19

Abstract Background In prior studies, HIV-1 BF recombinants with subtype F integrases failed to develop resistance raltegravir through the Q148H mutational pathway. We aimed determine role of subtype-specific polymorphisms in integrase on drug susceptibility, viral replication and integration. Methods Integrase sequences were retrieved from Los Alamos Database or obtained Garrahan HIV cohort. infectious molecular clones without (+ G140S) mutations constructed using B (NL4-3) F1(BF) ARMA159...

10.1093/jac/dkac238 article EN Journal of Antimicrobial Chemotherapy 2022-07-28

To compare closure rates and hearing outcomes of microscopic endoscopic tympanoplasty in pediatric patients.Retrospective chart review.Tertiary university medical center.Pediatric patients who underwent surgery by a fellowship-trained neurotologist between 2010 2019 with minimum 2 months follow-up, tympanic membrane perforation, no preoperative cholesteatoma.Transcanal or (MT) surgery.The primary outcome is postoperative the assessed using otomicroscopy at last follow-up appointment....

10.1097/mao.0000000000003694 article EN Otology & Neurotology 2022-09-27

Xanthomas are localized deposits of lipid-rich histiocytes (also known as foam cells) in the connective tissue. Various subtypes xanthomas described literature, including eruptive, tuberous, tendinous, planar, and verrucous.1 Cutaneous xanthomatous eruptions can be associated with systemic diseases such metabolic disease, familial hyperlipidemias, lymphoproliferative disorders.1,2

10.1016/j.jdcr.2023.08.004 article EN cc-by JAAD Case Reports 2023-08-19
Eloy E. Ordaya Daniel R. Ries Nikifor K. Konstantinov Sahana Ummadi Shelley Stepenaskie and 95 more Sharon E. Nunez David Y. Cao Jessica Zhou Carl Dernell Keri Chaney Karolyn A. Wanat Madiha Khan Katerina Warda Sarah Do A.N. Do Cindy Apple Charles Hoffman Pooja Gropper Paul Srivastava Christopher J. Fay Jacqueline Lippert Nicole R. LeBoeuf Drew Kuraitis Susan Pei Doniya Milani Katharine Hanlon Lilia Correa‐Selm James M. Grichnik Wei-Shen Chen Christopher Iriarte Dorsa Moslehi Jimmy Lam Igor Katsyv Kevin M. Burningham Ravi Patel Cristian D. Gonzalez Melissa Mauskar Travis Vandergriff Heather W. Goff William Lau Yasin Damji Gregory M. Orlowski Elizabeth V. Jones Alexander A. Valiga Miriam Solowey Gabriella Alvarez Larissa Rodriguez-Homs Rami N. Al‐Rohil Meenal Kheterpal Amber Fresco Katie Roster Rebecca Kann Alina Zufall Banu Farabi Marian Russo Kenneth I. Shulman Bijan Safai Patrick McMullan Regina Brown Lorin A. Bibb Katalin Ferenczi Christina Huang Adar Berghoff Jack L. Arbiser Michael J. Woodbury Rebecca G. Gaffney Joseph F. Merola Jamie Lebhar Jennifer Jacobs Khushnood Faraz April K.S. Salama Paul J. Mosca Karissa Libson Kristin L Koenig Catherine Chung Abraham M. Korman Zoha Momin Swapneel J. Patel Katherine Gordon Tatiana Barrera Omar Venegas Tiaranesha Jackson Yacine Sow Christopher Wachuku Rosalie Elenitsas Susan C. Taylor Nicholas Mollanazar Patricia Zhao Tappy J. Gish Diana Mannschreck Enrica Marchi Thomas G. Cropley Ryan Saal Luis J. Borda Melissa Hoffman Alice Roberts Abby Van Voorhees Jimena Agostina Miranda Charles Huvet Marie Donzel

10.1016/s0190-9622(23)02983-3 article EN Journal of the American Academy of Dermatology 2023-11-10
Kyle Seigel David Croitoru Orli M. Silverberg Yvette Miller-Monthrope Stéphane Laframboise and 95 more Marissa Joseph Gray-Brown Macules Julian Cortes Brian Hinds Genevieve J. Kaunitz Nishita Lockwood Shaman Bhullar Gauri Panse Jonathan S. Leventhal Sarah Williamson Stephen C. Somach Richard Bindernagel Krina Chavda Zoha Momin Aya Alame Travis Vandergriff Cristina Thomas Kaveh Nezafati Ariany Tomaz de Aquino Saran Denofre Ana Carolina Barbara Patrícia Santana Silva Carolina M. Stecca Renata Magalha ̃es Thaís Helena Buffo Nathan Vengalil Laurin M. Council Basia M. Michalski Maha Kazmi William R. Zhang Edward Hsiao Andrew Gross Katie Grouse Thomas M. Link Michael T. Tetzlaff Philip V. Theodosopoulos Anna Haemel Fatima Bawany Vignesh Ramachandran Eduardo Rodrı́guez Randie H. Kim Jeffrey S. Weber Ian Tattersall Rita Chen Christine C. Yokoyama Milan J. Anadkat Laeshelle Fitzpatrick Scale V Skin Narendra Persad Akil Olliverrie Rajeev Nagassar Salma Mohammed Jarred Brewster Christian Gan Daryl Johnson Christopher McAulay-Powell Clin Dip Robert Med Eric H. Kowalski Howard W. Kenney Christopher Richardson Ina Kreyberg E. Schrumpf Carl Fredrik von Krogh Rune Lilleng Geir E. Tjønnfjord Valeria Oliver-Garcı ́a Kevin Moore Thomas Denize Mai Hoang Victor Neel Shadmehr Demehri Fabrizio Martora Maria Carmela Annunziata Luigi Guerriero Teresa Battista Luca Potestio Matteo Megna Patrick McMullan Aziz Khan Jónas A. Aðalsteinsson Reid A. Waldman Campbell L. Stewart Brett Sloan Marti Jill Rothe Henning Klapproth Birte Stroucken Doris Helbig Iliana Tantcheva-Poo ́r Mario Fabri Refractory Haileyehailey Lauren Murphy Peter Ch’en Eingun James Song Advika Dani Harper Price Vanessa Gildenstern

10.1016/s0190-9622(23)03052-9 article EN Journal of the American Academy of Dermatology 2023-12-13

Objective: To compare the effects of preoperative medical comorbidities and operative findings on success lateral graft tympanoplasty. Study Design: Retrospective chart review. Setting: Tertiary center. Patients: Ninety-six patients undergoing tympanoplasty from December 2008 to November 2020 with at least 2 months follow-up were included. Patient demographics, including smoking status, intraoperative findings, healing, hearing outcomes recorded. Interventions: Lateral Main Outcome Measures:...

10.1097/ono.0000000000000015 article EN cc-by Otology & Neurotology Open 2022-07-20

Linear pigmented purpura, also known as unilateral linear capillaritis, is a clinical subtype of purpuric dermatoses (PPDs). Although several variants exist, the PPDs are benign group skin eruptions that present with petechiae and hyperpigmented macules, papules, and/or patches. Morphology, examination findings, histopathology differ across PPD subtypes.1,2 Thus far, exact etiology unknown.3

10.1016/j.jdcr.2022.08.049 article EN cc-by-nc-nd JAAD Case Reports 2022-09-03
Aline de Abreu Silvestre Sales Mendes Za ́u Ezaguy De Hollanda Louise Makarem Oliveira Ana Paula and 95 more Coelho Rocha Caroline Albuquerque Rodrigues Chirano Cecilya Melo M L Brito Barroso Maia De Souza Luciana Mendes Justin Qian Shelby L. Kubicki Jonathan L. Curry Richard R. Jahan‐Tigh Robert S. Benjamin Meghan Heberton Kelly A. Nelson Melissa C. Leeolou P. A. Young Allison Dear Saisindhu Narala Atif Saleem Kerri Do G. Rieger Luísa L. Macias Patrícia Santos Patrícia Motta de Morais Patricia Couto Mariana Chicre Bandeira De Melo Joelly Taynara Lapinski Levermann Monique Freire Santana Mohammad Yassine Che ́rif Marjolaine Weynand Prochore Kamgang Vale ́rie Badot Yora Mostmans Mahendra M. Kura Supreet Dhillon Fiona M Landells M.E. Pratt Sarah C. Finch Kathryn P. Whelan Krystina Khalil Claudia Green Derrek Giansiracusa Gabriella Vasile Eduardo Weiss Alexander Kollhoff Jeremy Greer Loretta S. Davis Lowell T. Nicholson Christina Topham Julia Curtis Lauren M. Madigan Kura Mahendra Usha Khemani Sangeeta Bharati Radhika Chavan Sarah J. Eley Sakeena Fatima Danny Barlev Bethany Rohr Jesus Gomez Hubert Huho Krishna Venkatarama Sharma Aashka Suvarnakar Amber Tribley Betsy Chavez Albert Huho Neal Gregory Karen Cravero Austin J. Maddy Kiran Motaparthi Brynn Sargent Lina Saeed Dani Zhao Anna‐Marie Hosking Hadas Skupsky Maryam Safaee Zoha Momin Travis Vandergriff Kaveh Nezafati Giovanni Paolino Santo Raffaele Mercuri Boulos Mansour Matteo Riccardo D. Di Nicola Manuela Carrera Silvia Taccogna Vittoria Giulia Bianchi Pietro Donati Michele Donati Rachel L. Sadowsky Catherine Ba David Emerson Shannon M. Nugent

10.1016/s0190-9622(22)03014-6 article EN Journal of the American Academy of Dermatology 2022-12-14

In article number 2000163, Alessandro Grattoni and colleagues perform the first ever HIV preventive efficacy study using a subcutaneous drug delivery implant. The implant uses nanofluidic membrane to sustainably deliver tenofovir alafenamide fumarate (TAF), antiretroviral, without pumps or actuation. Long-term sustained TAF release, controlled through physical electrostatic confinement in nanochannels of membrane, obviates daily oral dosing provide protection from infection nonhuman primates.

10.1002/adtp.202170005 article EN Advanced Therapeutics 2021-03-01
Coming Soon ...